Wess Jürgen
Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, DHHS, Bethesda, Maryland 20892, USA.
Annu Rev Pharmacol Toxicol. 2004;44:423-50. doi: 10.1146/annurev.pharmtox.44.101802.121622.
Muscarinic acetylcholine receptors (mAChRs; M1-M5) play key roles in regulating the activity of many important functions of the central and peripheral nervous system. Because of the lack of ligands endowed with a high degree of receptor subtype selectivity and the fact that most tissues or cell types express two or more mAChR subtypes, identification of the physiological and pathophysiological roles of the individual mAChR subtypes has proven a difficult task. To circumvent these difficulties, several laboratories recently employed gene-targeting techniques to generate mutant mouse strains deficient in each of the five mAChR subtypes. Phenotyping studies showed that each mutant mouse line displayed characteristic physiological, pharmacological, behavioral, biochemical, or neurochemical deficits. The novel insights gained from these studies should prove instrumental for the development of novel classes of muscarinic drugs.
毒蕈碱型乙酰胆碱受体(mAChRs;M1 - M5)在调节中枢和外周神经系统许多重要功能的活动中起关键作用。由于缺乏具有高度受体亚型选择性的配体,并且大多数组织或细胞类型表达两种或更多种mAChR亚型,因此确定各个mAChR亚型的生理和病理生理作用已被证明是一项艰巨的任务。为了克服这些困难,几个实验室最近采用基因靶向技术生成了五种mAChR亚型各自缺失的突变小鼠品系。表型研究表明,每个突变小鼠品系都表现出特征性的生理、药理、行为、生化或神经化学缺陷。从这些研究中获得的新见解应该对新型毒蕈碱药物的开发具有重要意义。